Literature DB >> 23426126

Histologic evaluation of prophylactic hysterectomy and oophorectomy in Lynch syndrome.

Yevgeniy Karamurzin1, Robert A Soslow, Karuna Garg.   

Abstract

Women with Lynch syndrome (LS) are at increased risk for endometrial (EC) and ovarian carcinoma (OC). Current surveillance recommendations for detection of EC and OC in LS patients are not effective. Small studies have shown that prophylactic hysterectomy and bilateral salpingo-oophorectomy (P-TH-BSO) are the most effective and least expensive preventive measures in these patients. Data regarding histologic findings in prophylactic specimens in these patients are lacking. All LS patients who underwent P-TH-BSO at the Memorial Sloan-Kettering Cancer Center from 2000 to 2011 were identified. Slides were evaluated for the presence of endometrial hyperplasia (EH), EC, OC, or any other recurrent histologic findings. Twenty-five patients were identified, with an age range of 36 to 61 years. Fifteen patients had a synchronous or prior colorectal carcinoma, and 2 patients had a history of sebaceous carcinoma. Focal FIGO grade 1 endometrioid ECs were detected in 2 patients; 1 was 54 years of age (MSH2 mutation; superficially invasive), and the other was 56 years of age (MLH1 mutation; noninvasive). Focal complex atypical hyperplasia, unassociated with carcinoma, was seen in 3 patients, ages 35 and 45 (MLH1 mutations) and 53 years (MSH2 mutation). One patient (44 y, with MSH2 mutation) was found to have a mixed endometrioid/clear cell OC and simple EH without atypia. The OC was adherent to the colon but did not show distant metastasis. In our study, P-TH-BSOs performed because of the presence of LS revealed incidental EC and/or EH in 24% of cases and OC in 4%. The ECs were low grade, confined to the endometrium, and seen in patients older than 50 years. Prophylactic hysterectomy allows detection of early lesions in LS; these lesions appear to be small and focal. This small series of prophylactic hysterectomies may provide some clues about LS-associated endometrial carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23426126     DOI: 10.1097/PAS.0b013e3182796e27

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  8 in total

1.  Comparison of lifestyle, hormonal and medical factors in women with sporadic and Lynch syndrome-associated endometrial cancer: A retrospective case-case study.

Authors:  Mari H Aaltonen; Synnöve Staff; Jukka-Pekka Mecklin; Kirsi Pylvänäinen; Johanna U Mäenpää
Journal:  Mol Clin Oncol       Date:  2017-04-06

2.  Loss of Mismatch Repair Protein Expression in Unselected Endometrial Adenocarcinoma Precursor Lesions.

Authors:  Koah Robin Vierkoetter; Laura A T Kagami; Hyeong Jun Ahn; David M Shimizu; Keith Y Terada
Journal:  Int J Gynecol Cancer       Date:  2016-02       Impact factor: 3.437

3.  Management strategies in Lynch syndrome and familial adenomatous polyposis: a national healthcare survey in Japan.

Authors:  Tomoki Yamano; Michiko Hamanaka; Akihito Babaya; Kei Kimura; Masayoshi Kobayashi; Miki Fukumoto; Kiyoshi Tsukamoto; Masafumi Noda; Nagahide Matsubara; Naohiro Tomita; Kenichi Sugihara
Journal:  Cancer Sci       Date:  2017-02       Impact factor: 6.716

Review 4.  The practice of universal screening for Lynch syndrome in newly diagnosed endometrial carcinoma.

Authors:  Aifen Wang; Jenna McCracken; Yanjing Li; Lingfan Xu
Journal:  Health Sci Rep       Date:  2018-06-14

5.  Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review.

Authors:  Natalie Lim; Martha Hickey; Graeme P Young; Finlay A Macrae; Christabel Kelly
Journal:  Int J Gynecol Cancer       Date:  2022-05-03       Impact factor: 4.661

Review 6.  The genetic basis of Lynch syndrome and its implications for clinical practice and risk management.

Authors:  Stephanie A Cohen; Anna Leininger
Journal:  Appl Clin Genet       Date:  2014-07-22

7.  Incidental placenta increta at the time of prophylactic hysterectomy for Lynch syndrome: Insights into individualized decision-making and surgical timing.

Authors:  Tara A Nielsen; Stephanie N David; Mohamed M Desouki; Marta A Crispens; Dineo Khabele
Journal:  Gynecol Oncol Rep       Date:  2015-09-25

8.  Letter to the Editor regarding the manuscript entitled: "Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome" by Lachiewicz et al. (Gynecol Oncol. 2014; 132: 434-437).

Authors:  Robert A Soslow
Journal:  Gynecol Oncol Rep       Date:  2014-11-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.